Tirzepatide, on the other hand, is a newer medication that also targets both GLP-1 and GIP receptors but has gained significant attention due to its impressive results in clinical trials and recent FDA approval for type 2 diabetes treatment
Conclusions Recently, many compounds, discovered through computer-based gene-profiling, were proposed as novel therapeutics
B12 supplementation during GLP-1 therapy makes physiological sense
Reduce portion sizes semaglutide slows gastric emptying, so large meals will sit heavily and increase nausea risk
Combination start only after stabilization on GLP-1 (2.4 mg or 5 mg)
Muscle and aging research More recent research has explored how NNMT inhibition affects muscle function, particularly in the context of aging